Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Public ClinicalTrials.gov record NCT01748877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Study identification
- NCT ID
- NCT01748877
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NeurAxon Inc.
- Industry
- Enrollment
- 188 participants
Conditions and interventions
Conditions
Interventions
- NXN-462 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2012
- Primary completion
- May 31, 2014
- Completion
- May 31, 2014
- Last update posted
- Jun 18, 2014
2013 – 2014
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Premier Research | Phoenix | Arizona | 85027 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Neurological Research Institute | Santa Monica | California | — | — |
| Meridien Research | Brooksville | Florida | 34601 | — |
| FPA Clinical Research | Kissimmee | Florida | 34741 | — |
| Suncoast Clinical Research | New Port Richey | Florida | — | — |
| Compass Research LLC | Orlando | Florida | 32806 | — |
| Meridien Research | Tampa | Florida | 33606 | — |
| Medex Healthcare Research, Inc. | Chicago | Illinois | 60602 | — |
| Integrated Clinical Trial Services | West Des Moines | Iowa | — | — |
| IRC Clinics | Towson | Maryland | 21204 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Michigan Head-Pain and Neurological Institute | Ann Arbor | Michigan | — | — |
| Albuquerque Clinical Trials, Inc | Albuquerque | New Mexico | 87102 | — |
| Clinical Trials of America, Inc. | Hickory | North Carolina | 01845 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Pain Specialist of Charleston, P.A. | Mt. Pleasant | South Carolina | — | — |
| Nashville Neuroscience Group | Nashville | Tennessee | 37203 | — |
| Trinity Clinical Research | Tullahoma | Tennessee | 37388 | — |
| ClinRx Research LLC | Plano | Texas | 75080 | — |
| Progressive Clinical Research | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01748877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01748877 live on ClinicalTrials.gov.